Atossa Therapeutics Inc - ESG Rating & Company Profile powered by AI
Full Sustainability analysis of Atossa Therapeutics Inc can be accessed by registering for free. This article includes a questions and answers table on Atossa Therapeutics Inc. This assessment of Atossa Therapeutics Inc leverages intelligence from across the web and also from available filings by Atossa Therapeutics Inc.
Atossa Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 2.7, social score of 5.7 and governance score of 2.0.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1575 | Vitality Biopharma Inc | 3.6 | Medium |
| 1575 | Zhejiang East Asia Pharmaceutical Co Ltd | 3.6 | Medium |
| 1617 | Atossa Therapeutics Inc | 3.5 | Medium |
| 1617 | Anika Therapeutics Inc | 3.5 | Medium |
| 1617 | Aerovate Therapeutics Inc | 3.5 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Atossa Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Atossa Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Atossa Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Atossa Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Atossa Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Atossa Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Atossa Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Atossa Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Atossa Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Atossa Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Atossa Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Atossa Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Atossa Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Atossa Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Atossa Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Atossa Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Atossa Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Atossa Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.